Microbot Medical Inc reports results for the quarter ended June 30 - Earnings Summary

• Microbot Medical Inc MBOT.OQ reported a quarterly adjusted loss of 10 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -17 cents. The lone analyst forecast for the quarter was for a loss of 8 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Microbot Medical Inc's reported EPS for the quarter was a loss of 10 cents​.

• Microbot Medical Inc shares had risen by 14.7% this quarter and gained 158.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 33.3% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Microbot Medical Inc is $9.00, about 65.3% above its last closing price of $3.12

This summary was machine generated from LSEG data August 12 at 09:55 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)